Coronavirus antiviral resistance database (Robert Shafer)

Shafer’s team has created an online database of compounds with proven or potential anti-COVID-19 activity. The compounds include targeted anti-virals, repurposed drugs, investigational agents and other compounds that inhibit virus replication. The data come from published biochemical, cellular, small animal, nonhuman primate and human clinical studies. The goal of the database is to provide a uniform way to report experimental results, enabling comparisons between different compounds and allowing prioritization for further development. Stanford Office of Technology Licensing 650-723-0651

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More